7.05% 0.67

Amicus Therapeutics Inc (FOLD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FOLD? Forum Prognose

Finanzdaten der Amicus Therapeutics Inc-Aktie (FOLD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.50% 154.69	125.25	141.52	126.67	110.40
Cost Of Revenue	30.08% 15.22	11.70	13.28	11.26	13.57
Gross Profit	22.83% 139.47	113.55	128.24	115.41	96.84
Operating Expenses	22.59% 148.94	121.50	106.58	100.44	124.56
Benefits Costs and Expenses	21.34% 173.87	143.29	134.73	126.56	153.99
Costs And Expenses	21.34% 173.87	143.29	134.73	126.56	153.99
Operating Income/Loss	19.14% -9.474	-7.952	21.66	14.97	-27.72
Income/Loss From Continuing Operations Before Tax	6.30% -19.18	-18.05	6.785	0.108	-43.58
Income Tax Expense/Benefit	43.89% 5.239	3.641	13.51	15.80	4.836
Income/Loss From Continuing Operations After Tax	12.61% -24.42	-21.69	-6.729	-15.70	-48.42
Net Income/Loss	12.61% -24.42	-21.69	-6.729	-15.70	-48.42
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.18% 308.25	307.69	304.69	303.77	302.90
Diluted Average Shares	0.18% 308.25	307.69	304.69	303.77	302.90
Basic Earnings Per Share	14.29% -0.08	-0.07	-0.02	-0.05	-0.16
Diluted Earnings Per Share	14.29% -0.08	-0.07	-0.02	-0.05	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.21%

GMAB

$28.82

0.28%

INCY

$100.47

1.20%

BNTX

$103.56

0.30%

ONC

$309.05

0.62%

INSM

$185.53

0.71%